rs63751273

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong

The NM_001377265.1(MAPT):​c.2078C>A​(p.Pro693Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000703 in 1,421,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P693S) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

MAPT
NM_001377265.1 missense

Scores

14
4
1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 7.38

Publications

0 publications found
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
MAPT Gene-Disease associations (from GenCC):
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • semantic dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • supranuclear palsy, progressive, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • late-onset Parkinson disease
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • progressive supranuclear palsy-parkinsonism syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 6 uncertain in NM_001377265.1
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr17-46010388-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 14256.Status of the report is no_assertion_criteria_provided, 0 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.967

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPTNM_001377265.1 linkc.2078C>A p.Pro693Gln missense_variant Exon 10 of 13 ENST00000262410.10 NP_001364194.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPTENST00000262410.10 linkc.2078C>A p.Pro693Gln missense_variant Exon 10 of 13 1 NM_001377265.1 ENSP00000262410.6 A0A7I2PJZ2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.03e-7
AC:
1
AN:
1421916
Hom.:
0
Cov.:
31
AF XY:
0.00000142
AC XY:
1
AN XY:
703076
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32888
American (AMR)
AF:
0.00
AC:
0
AN:
38606
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25414
East Asian (EAS)
AF:
0.0000261
AC:
1
AN:
38276
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50736
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1090516
Other (OTH)
AF:
0.00
AC:
0
AN:
58964
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Pathogenic
0.55
CADD
Pathogenic
32
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.89
D;.;.;.;.;.;.;D;.
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.83
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.96
D;D;D;D;D;.;.;.;.
M_CAP
Pathogenic
0.46
D
MetaRNN
Pathogenic
0.97
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.2
M;.;.;.;.;.;.;M;.
PhyloP100
7.4
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-6.2
D;D;D;D;D;D;D;.;.
REVEL
Pathogenic
0.91
Sift
Pathogenic
0.0
D;D;D;D;D;D;D;.;.
Sift4G
Pathogenic
0.0010
D;D;D;D;D;D;D;D;D
Polyphen
1.0
D;D;D;D;D;D;D;D;D
Vest4
0.81
MutPred
0.88
Gain of solvent accessibility (P = 0.0365);.;.;.;.;.;.;Gain of solvent accessibility (P = 0.0365);.;
MVP
1.0
MPC
2.0
ClinPred
1.0
D
GERP RS
5.3
Varity_R
0.96
gMVP
0.98

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs63751273; hg19: chr17-44087755; API